-
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
-
-
People are either equol producers or nonequol producers, and the clinical benefits of soy isoflavones may be limited to equol producers.
-
An electrosurgical bipolar vessel sealer reduces the operating time and blood loss in a series of vaginal hysterectomies.
-
Early experience with fetal MMC repair suggests a decreased need for ventriculoperitoneal shunting, arrest, or slowing of progressive ventriculomegaly, and consistent resolution of hindbrain herniation.
-
Menstrual irregularities are arguably the mainstay of gynecologic office practice. The differential diagnosis for this common presentation is quite extensive, but a common cause is reduced central hypothalamic GnRH drive due to lifestyle issues.
-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
-
Despite guidelines presented by several organizations, significant numbers of women with ovarian cancer are not being provided with appropriate care.
-
-
In an intent-to-treat analysis, the use of conjugated equine estrogen combined with continuous medroxyprogesterone acetate by menopausal women increased the hazard ratio of invasive breast cancer to 1.24.
